AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,506,000 | -24.1% | 165,000 | 0.0% | 0.40% | -18.8% |
| Q3 2018 | $3,300,000 | -30.9% | 165,000 | -32.7% | 0.50% | -30.7% |
| Q2 2018 | $4,778,000 | -3.2% | 245,000 | 0.0% | 0.71% | -9.5% |
| Q1 2018 | $4,937,000 | +63.9% | 245,000 | +50.0% | 0.79% | +57.8% |
| Q3 2017 | $3,013,000 | +9.1% | 163,300 | +8.8% | 0.50% | +5.3% |
| Q2 2017 | $2,762,000 | +2.0% | 150,100 | +25.0% | 0.48% | +13.9% |
| Q1 2017 | $2,708,000 | -24.5% | 120,100 | +16.5% | 0.42% | -31.0% |
| Q4 2016 | $3,588,000 | +42.0% | 103,100 | 0.0% | 0.60% | +23.8% |
| Q3 2016 | $2,527,000 | +19.9% | 103,100 | +17.0% | 0.49% | +16.7% |
| Q2 2016 | $2,107,000 | +2.2% | 88,100 | 0.0% | 0.42% | +6.1% |
| Q1 2016 | $2,062,000 | – | 88,100 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |